AbbVie (NYSE: ABBV) confirmed it delivered strong sales growth with its marketed pharmaceutical products in 2012. The proprietary pharmaceutical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE